Parallax Volatility Advisers’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Buy |
+7,035
| New | +$342K | ﹤0.01% | 358 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 698 |
|
|
2023
Q4 | – | Sell |
-32,646
| Closed | -$1.48M | – | 748 |
|
|
2023
Q3 | $1.48M | Buy |
+32,646
| New | +$1.48M | ﹤0.01% | 253 |
|
|
2023
Q2 | – | Sell |
-23,442
| Closed | -$1.06M | – | 835 |
|
|
2023
Q1 | $1.06M | Buy |
+23,442
| New | +$1.06M | ﹤0.01% | 297 |
|
|
2022
Q4 | – | Sell |
-7,223
| Closed | -$472K | – | 1048 |
|
|
2022
Q3 | $472K | Buy |
+7,223
| New | +$472K | ﹤0.01% | 491 |
|
|
2022
Q2 | – | Sell |
-25,445
| Closed | -$1.6M | – | 1126 |
|
|
2022
Q1 | $1.6M | Buy |
+25,445
| New | +$1.6M | ﹤0.01% | 312 |
|